9 results
DEF 14A
MLYS
Mineralys Therapeutics Inc
9 Apr 24
Definitive proxy
7:15am
, and reputational risk.
The audit committee reviews information regarding liquidity and operations and oversees our management of financial risks. Periodically
10-Q
2zk1r68q6c1 gk
15 May 23
Quarterly report
5:25pm
DRS/A
5ijx9j bi
29 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
1b9amu1c1
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
8w3wbq5cgjlw0m
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next